CD274 and neoplasm: Often, the immunotherapy is not enough to overcome the tumor immunosuppressive environment, led by tumor-associated macrophages and other lymphocytes that secrete cytokines that trigger the production of checkpoint molecules like PD-1 and PD-L1 (20–23).